Its manufacturer, Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, has not issued any Elmiron recalls or pulled the drug from the market
Patients typically notice: Steady weekly weight loss Better portion control Increased energy Average total weight loss: 1015 pounds by the end of month 3
Abstract: Pullar, J., Carr, A., & Vissers, M
Over one-third of the ACMG secondary findings genes have pharmacogenomic implications, emphasizing the need for clinicians to integrate genetic insights into prescribing practices
Nano-Phytosome: a developing platform for herbal anti-cancer agents in cancer therapy
Limitations: Although increased GGT levels can indicate liver problems, they cannot identify the exact cause of the problem (like hepatitis, cirrhosis, or cancer)